Collaborative Computational Technologies for Biomedical by Sean Ekins

By Sean Ekins

Tools, methods, and instruments for Collaboration"The time has come to essentially reconsider how we deal with the development of information in biomedical sciences this present day. This booklet describes how the computational sciences have remodeled into being a key wisdom dealer, in a position to combine and function throughout divergent info types."—Bryn Williams-Jones, affiliate study Fellow, PfizerThe pharmaceutical makes use of a longer community of accomplice companies with the intention to realize and advance new medicinal drugs, notwithstanding there's at present little suggestions for handling info and assets throughout collaborations. that includes contributions from the top specialists in a variety of industries, Collaborative Computational applied sciences for Biomedical study presents info that might aid organisations make serious judgements approximately coping with partnerships, together with: Serving as a consumer guide for collaborations Tackling actual difficulties from either human collaborative and information and informatics views supplying case histories of biomedical collaborations and technology-specific chapters that stability technological intensity with accessibility for the non-specialist readerA must-read for somebody operating within the prescription drugs or academia, this publication marks a tremendous step in the direction of frequent collaboration facilitated by way of computational applied sciences.

Show description

Read or Download Collaborative Computational Technologies for Biomedical Research PDF

Best pharmacy books

Optimization in Drug Discovery: In Vitro Methods

Completely revised and up to date, Optimization in Drug Discovery: In Vitro tools, moment version provides a large spectrum of in vitro assays together with formula, plasma binding, absorption and permeability, cytochrome P450 (CYP) and UDP-glucuronosyltransferases (UGT) metabolism, CYP inhibition and induction, drug transporters, drug-drug interactions through overview of reactive metabolites, genotoxicity, and chemical and photo-mutagenicity assays.

Drug Calculations for Nurses : A step-by-step approach, Fourth Edition

The management of medicines in hospitals has develop into more and more advanced. It occasionally contains effective medicines which may be deadly if administered incorrectly. the facility to accomplish drug calculations properly is as a result paramount to avoid putting sufferers in danger. Drug Calculations for Nurses: A step by step procedure teaches healthcare pros how you can practice drug calculations with self assurance and competence.

Good Pharma: The Public-Health Model of the Mario Negri Institute

Drawing on key options in sociology and administration, this background describes a extraordinary institute that has increased scientific study and labored out strategies to the troubling practices of industrial pharmaceutical examine. reliable Pharma is the reply to Goldacre's undesirable Pharma: moral learn with no advertisement distortions.

Progress in medicinal chemistry

Growth in Medicinal Chemistry presents a assessment of eclectic advancements in medicinal chemistry. This quantity comprises chapters overlaying contemporary advances in melanoma therapeutics,  fluorine in medicinal chemistry, a  point of view at the subsequent iteration of antibacterial brokers derived by means of manipulation of traditional items, a  new period for Chagas ailment drug discovery?

Additional resources for Collaborative Computational Technologies for Biomedical Research

Example text

5). 2 Sequence Services Most major pharmaceutical companies currently host a large number of sequence data and analysis tools within their firewalls. 5 15 Schematic Architecture for SESL project. genes, these services offered a competitive advantage, and consequently each company built and maintained vast internal systems that both took external public data and merged it with internal private data. However, in the past five years the public domain has caught up (and in many cases surpassed) the expensive, heavily customized commercial and proprietary solutions used by industry.

These multidisciplinary breakthroughs are not just complex, they are also very expensive. Thus it becomes imperative for companies, universities, and laboratories to work in a seamless, synchronistic, and synergistic manner. The Langer Laboratory at MIT is a perfect example, as Dr. Robert Langer describes[1]: My lab has people with 10–12 different disciplines in it—molecular biologists, cell biologists, clinicians, pharmacists, chemical engineers, electrical engineers, materials scientists, physicists, and others.

If the need to transmit compound registration data between business partners was a unique event, then perhaps a manual reconciliation process would suffice. However, since every pharmaceutical company has several synthesis outsourcing partners, and every synthesis CRO has several pharmaceutical clients, this metadata-conflict and reconciliation process is 10 NEED FOR COLLABORATIVE TECHNOLOGIES IN DRUG DISCOVERY repeated over and over throughout the industry. While this problem of data reconciliation and reformatting is time consuming and error prone in the chemical synthesis domain, this problem is often even more exacerbated in the biological domain.

Download PDF sample

Rated 4.38 of 5 – based on 41 votes